Diabetes

Plasma volume changes may mediate effects of empagliflozin

(HealthDay)—The reduction in risk of cardiovascular (CV) death with empagliflozin is most mediated by changes in hematocrit and hemoglobin, according to research published online Dec. 4 in Diabetes Care.

Cardiology

Intensive BP goals reduce risk of cardiovascular events

(HealthDay)—Intensive blood pressure lowering may similarly decrease cardiovascular events in both patients with and patients without type 2 diabetes mellitus, according to a study published online Dec. 6 in Diabetes Care.

Diabetes

Microbiome intervention with niacin aids insulin sensitivity

(HealthDay)—A targeted microbiome intervention, accomplished through microencapsulated delayed-release niacin, beneficially affects insulin sensitivity in humans, according to a study published online Dec. 6 in Diabetes ...

Diabetes

Expanded TIMI risk score deemed practical in diabetes

(HealthDay)—The TIMI (Thrombolysis in Myocardial Infarction) Risk Score for Secondary Prevention (TRS 2°P) is an accurate predictor of atherothrombotic disease among patients with type 2 diabetes, according to a study ...

Diseases, Conditions, Syndromes

Understanding and preventing gangrene

Dear Mayo Clinic: I have heard that a stubbed toe can lead to gangrene in some individuals. Is that true? What are the signs of gangrene, and how can it be avoided?

page 38 from 40